Nexthera Capital

Nexthera Capital as of March 31, 2019

Portfolio Holdings for Nexthera Capital

Nexthera Capital holds 24 positions in its portfolio as reported in the March 2019 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Audentes Therapeutics 11.9 $9.8M 251k 39.02
Heron Therapeutics (HRTX) 11.5 $9.5M 389k 24.44
Insmed (INSM) 10.0 $8.3M 284k 29.07
Immunomedics 7.8 $6.4M 335k 19.21
Bausch Health Companies (BHC) 6.2 $5.1M 206k 24.70
Urogen Pharma (URGN) 5.9 $4.9M 133k 36.94
Global Blood Therapeutics In 5.6 $4.6M 87k 52.93
D Stemline Therapeutics 5.1 $4.2M 326k 12.85
Novartis (NVS) 4.7 $3.8M 45k 84.58
Amarin Corporation (AMRN) 3.8 $3.1M 149k 20.76
Cymabay Therapeutics (CBAY) 3.4 $2.8M 210k 13.28
Sarepta Therapeutics (SRPT) 3.1 $2.5M 21k 119.18
Uniqure Nv (QURE) 2.8 $2.3M 39k 59.64
Exelixis (EXEL) 2.6 $2.1M 90k 23.79
Neurocrine Biosciences (NBIX) 2.6 $2.1M 24k 88.10
Acorda Therapeutics 2.5 $2.1M 155k 13.29
Allergan 2.4 $2.0M 14k 146.42
Intercept Pharmaceuticals In 1.6 $1.3M 12k 111.86
Kiniksa Pharmaceuticals (KNSA) 1.5 $1.2M 68k 18.07
Chiasma 1.3 $1.1M 204k 5.20
Deciphera Pharmaceuticals (DCPH) 1.2 $995k 43k 23.21
Sage Therapeutics (SAGE) 1.2 $986k 6.2k 159.03
BioMarin Pharmaceutical (BMRN) 0.9 $733k 8.3k 88.85
Madrigal Pharmaceuticals (MDGL) 0.5 $432k 3.5k 125.14